ArticleBiomedical reports2014

Comparison of the serum fibrin-fibrinogen degradation products with cytokeratin 19 fragment as biomarkers in patients with lung cancer.

Hee Jin So et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.